Of patients identified as low risk by combined clinicopathological factors and GEP test, only 7.1% were SLN-positive.
The NIH has awarded a $3 million research grant to CND Life Sciences to initiate a 3-year multicenter study to evaluate the validity of a skin punch biopsy test to determine risk for Parkinson’s ...
Guardant Health (($GH)) announced an update on their ongoing clinical study. Study Overview: The SIBYL study, officially titled ‘obServation of ...
MONDAY, Oct. 27, 2025 (HealthDay News) — An already-available genetic test might spare some melanoma patients from a surgical ...
Everyday Health on MSN
What Is a Prostate Biopsy?
A prostate biopsy involves removing prostate tissue to test for cancer. Learn about types, procedure, risks, and follow-up ...
Liquid biopsies analyze materials like circulating tumor DNA (ctDNA) in the blood to provide a non-invasive look at a cancer’s genetic profile. They are highly effective for tracking tumor evolution, ...
The Seestar S30 is introduced as a compact, all-in-one astroimaging system by ZWO, designed for capturing deep-sky objects through integrated optics, automated tracking, and a user-friendly software ...
NORWICH, England — After years of being told their crushing exhaustion might be “all in their head,” people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome may finally have something they’ve ...
SCOTTSDALE, Ariz., Oct. 7, 2025 /PRNewswire/ -- CND Life Sciences, Inc. (CND), a medical technology company pioneering the development of cutaneous neurodiagnostic tests and associated biomarker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback